Immunotherapy Use in Advanced Lymphoid Malignancies

EP. 1: Immunotherapy: What is the Role in Lymphoid Cancers?

July 20th 2016

EP. 2: Immunotherapy Response Among Hematologic Malignancies

July 20th 2016

EP. 3: PD-1 Inhibitors in Hodgkin Lymphoma

July 20th 2016

EP. 4: Immunotherapy in Refractory DLBCL

July 20th 2016

EP. 5: Immunotherapy for Follicular Lymphoma

July 20th 2016

EP. 6: The Potential for Combining Checkpoint Inhibitors

July 20th 2016

EP. 7: CAR-T Cell Therapy in Hematologic Malignancies

July 20th 2016

EP. 8: Obstacles to Using CAR-T Therapy in Hematologic Malignancies

July 20th 2016

EP. 9: Toxicity Management for CAR-T in Hematologic Malignancies

July 20th 2016

EP. 10: Recent Trials of CAR-T Therapy

July 20th 2016

EP. 11: Where Does CAR-T Fit in the Context of Transplant?

July 20th 2016

EP. 12: Resistance with CAR-T Therapy

July 20th 2016

EP. 13: Immunochemotherapy for Lymphoma

July 20th 2016

EP. 14: Obinutuzumab for Indolent Lymphoma

July 20th 2016

EP. 15: Anti-CD20 Antibodies for Advanced Hematologic Malignancies

July 20th 2016

EP. 16: Brentuximab Vedotin in Advanced Lymphoid Malignancies

July 20th 2016

EP. 17: Where Immuno-Oncology Is Heading

July 20th 2016